Title | Author | Journal Issue |
JPEN Journal Club 82. Stepped-wedge cluster randomized trials | Ronald L. Koretz, MD | First Published January 31, 2024 |
JPEN Journal Club 81. Not all systematic reviews are created equal | Ronald L. Koretz, MD | First Published November 28, 2023 |
JPEN Journal Club 80. Prespecified outcomes | Ronald L. Koretz, MD | First Published October 18, 2023 |
JPEN Journal Club 79. If it may, it also may not | Ronald L. Koretz, MD | First Published July 27, 2023 |
JPEN Journal Club 78. Response-adaptive randomization | Ronald L. Koretz, MD | First Published June 28, 2023 |
JPEN Journal Club 77. Adjusting for confounders | Ronald L. Koretz, MD | First Published April 8, 2023 |
JPEN Journal Club 76. Randomized crossover trials | Ronald L. Koretz, MD | First Published March 4, 2023 |
JPEN Journal Club 75. When the headline does not match the study | Ronald L. Koretz, MD | First Published January 16, 2023 |
JPEN Journal Club 74. Regression to the mean | Ronald L. Koretz, MD | First Published November 29, 2022 |
JPEN Journal Club 73. When it is Too Good to be True | Ronald L. Koretz, MD | First Published October 1, 2022 |
JPEN Journal Club 72. The Devil in the Details | Ronald L. Koretz, MD | First Published August 16, 2022 |
JPEN Journal Club 71. Statistical Significance vs Truth | Ronald L. Koretz, MD | First Published June 21, 2022 |
JPEN Journal Club 70. Proof of Concept | Ronald L. Koretz, MD | First Published May 8, 2022 |
JPEN Journal Club 69. Umbrella Reviews | Ronald L. Koretz, MD | First Published February 28, 2022 |
JPEN Journal Club 68. Type I Errors | Ronald L. Koretz, MD | First Published January 24, 2022 |
JPEN Journal Club 67. Fixed-effect and Random-effects Models | Ronald L. Koretz, MD | First Published December 3, 2021 |
JPEN Journal Club 66. Mendelian Randomization | Ronald L. Koretz, MD | First Published November 16, 2021 |
JPEN Journal Club 65. Selective Citation | Ronald L. Koretz, MD | First Published September 5, 2021 |
JPEN Journal Club 64. Incorrect Statistics | Ronald L. Koretz, MD | First Published August 1, 2021 |
JPEN Journal Club 63. Retrospective Analyses of Prospective Studies | Ronald L. Koretz, MD | First Published May 12, 2021 |
JPEN Journal Club 62. Reporting of Randomized Trials | Ronald L. Koretz, MD | First Published April 7, 2021 |
JPEN Journal Club 61. Testing Hypotheses | Ronald L. Koretz, MD | First Published March 11, 2021 |
JPEN Journal Club 60. AGREE II | Ronald L. Koretz, MD | First Published January 19, 2021 |
JPEN Journal Club 59. Standards for Review Articles | Ronald L. Koretz, MD | First Published December 3, 2020 |
JPEN Journal Club 58. Case Report | Ronald L. Koretz, MD | First Published September 11, 2020 |
JPEN Journal Club 57. The Hawthorne Effect | Ronald L. Koretz, MD | First Published July 22, 2020 |
JPEN Journal Club 56. Primary Outcomes | Ronald L. Koretz, MD | First Published June 29, 2020 |
JPEN Journal Club 55. Best‐ and Worst‐Case Scenarios | Ronald L. Koretz, MD | First Published May 22, 2020 |
JPEN Journal Club 54. Correlation Coefficients | Ronald L. Koretz, MD | First Published May 15, 2020 |
JPEN Journal Club 53. The Narrative Review | Ronald L. Koretz, MD | First Published March 30, 2020 |
JPEN Journal Club 52. What Evidence Will Change Minds? | Ronald L. Koretz, MD | First Published March 6, 2020 |
JPEN Journal Club 51. Confidence Intervals | Ronald L. Koretz, MD | First Published February 3, 2020 |
JPEN Journal Club 50. Trial Sequential Analysis | Ronald L. Koretz, MD | First Published February 4, 2020 |
JPEN Journal Club 49. Pilot Trials | Ronald L. Koretz, MD | October 2019 |
JPEN Journal Club 48. When Systematic Reviews Differ | Ronald L. Koretz, MD | September 2019 |
JPEN Journal Club 47. How Good Should Evidence Be? | Ronald L. Koretz, MD | August 2019 |
JPEN Journal Club 46. Data Dredging | Ronald L. Koretz, MD | May 2019 |
JPEN Journal Club 45. Cluster Randomization | Ronald L. Koretz, MD | April 2019 |
JPEN Journal Club 44. When Not to Combine Data | Ronald L. Koretz, MD | March 2019 |
JPEN Journal Club 43. Stratification | Ronald L. Koretz, MD | February 2019 |
JPEN Journal Club 42. Factorial Design | Ronald L. Koretz, MD | February 2019 |
JPEN Journal Club 41. Propensity Scoring | Ronald L. Koretz, MD | January 2019 |
JPEN Journal Club 40. Differences in Nominal Significance | Ronald L. Koretz, MD | November 2018; 43 (2) |
JPEN Journal Club 39. Validating a Surrogate | Ronald L. Koretz, MD | October 2018; 43 (1) |
JPEN Journal Club 38. One‐Tailed Testing | Ronald L. Koretz, MD | September 2018; 42 (8) |
JPEN Journal Club 37. Placebos and Nocebos | Ronald L. Koretz, MD | August 2018; 42 (7) |
JPEN Journal Club 36. Quasirandomization | Ronald L. Koretz, MD | June 2018; 42 (6) |
JPEN Journal Club 35. Selective Data Presentation | Ronald L. Koretz, MD | May 2018; 42 (5) |
JPEN Journal Club 34. Suspecting Causation in an Association | Ronald L. Koretz, MD | March 2018; 42 (4) |
JPEN Journal Club 33. The Type II Error | Ronald L. Koretz, MD | January 2018; 42 (3) |
JPEN Journal Club 32. Adjusting for Confounding | Ronald L. Koretz, MD | January 2018; 42 (2) |
JPEN Journal Club 31. Heterogeneity | Ronald L. Koretz, MD | November 2017; 41 (8) |
JPEN Journal Club 30. The Cochrane Systematic Review—Data Collection and Assessment | Ronald L. Koretz, MD | October 2017; 41 (7) |
JPEN Journal Club 29. The Cochrane Systematic Review—Methodology | Ronald L. Koretz, MD | October 2017; 41 (6) |
JPEN Journal Club 28. Dealing With Dropouts | Ronald L. Koretz, MD | July 2017; 41 (5) |
JPEN Journal Club 27. Vested Interests | Ronald L. Koretz, MD | May 2017; 41 (4) |
JPEN Journal Club 26. Small Trials With Dramatic Findings | Ronald L. Koretz, MD | March 2017; 41 (3) |
JPEN Journal Club 25. Study Design | Ronald L. Koretz, MD | January 2017; 41 (2) |
JPEN Journal Club 24. Study Premise | Ronald L. Koretz, MD | December 2016; 41 (1) |
JPEN Journal Club 23. GRADEing Guidelines | Ronald L. Koretz, MD | November 2016; 40 (8) |
JPEN Journal Club 22. Superiority, Noninferiority, and Equivalence | Ronald L. Koretz, MD | September 2016; 40 (7) |
JPEN Journal Club 21. Systematic Reviews and Strength of Evidence | Ronald L. Koretz, MD | August 2016; 40 (6) |
JPEN Journal Club 20. Is the Guideline Already Out of Date? | Ronald L. Koretz, MD | July 2016; 40 (5) |
JPEN Journal Club 19. The Data vs the Message | Ronald L. Koretz, MD | May 2016; 40 (4) |